Tissue Engineering and Regenerative Medicine

De la Parra-Solomon is an entrepreneur focused on Information Technology, Education, and Health. He is creative, results-driven, and has 16+ years of Digital Strategy experience in architecture and implementation. De la Parra-Solomon is the Chief Strategy Officer and Co-Founder of the Quantum Brain Research Institute (www.quantumbrain.institute), a HealthTech initiative established in Tallinn, Estonia focused on Mental Health and Information Technology solutions. He serves as COO and Co-founding Partner at The Solomon Brokerage Firm. He also leads as Vice President of Digital Strategy at Mass Media Division, while being the CEO of De la Parra Mobile Solutions. He is the former Vice President of Strategy and Operations PetroM Corp and its subdivision PetroM Logistics and PetroM Pharma, the former COO & Co-founder at RegenerAge Clinic & RegenerAge Beauty. Mr. De la Parra-Solomon is the former CEO & Founder at Astrum Salud Móvil and its Telemedicine service Astrum Móvil, former Digital Strategy Director & Co-founder at Dr. Jois, BiorganicAging, What Skin Needs/WSN International Pty. Ltd. He also served as a member of the Board of Advisors and is former Chief Marketing Officer at ReAnima Advanced Biosciences and served as Digital Media Director at Bioquark, Inc. He also served as the Latin America Region Manager and Digital Strategy adviser at CardiacSense and is former CITO & Senior Partner at Cerezo Editores. Within the academic and educational fields, De la Parra-Solomon acted as the Executive Vice President: Executive Chairman of the WAMS Mobile Health Division, WAMS Chief Coordinating Officer, as a former member of the WAMS Executive Council (WAMS Executive Board), a former member of the WAMS Education & Training Board (ETB), a former member of the WAMS Editorial Board, an Honorary Member of the Academy Faculty FWAMS, an Honorary Fellow of the Academy & was also a Senior Partner at WAMS, The World Academy of Medical Sciences. He was also an Advisory Board member, functioned as the Chief Operating Officer and was a Co-founding Partner at The Reprogramming Medicine Association. De la Parra-Solomon is also a member of Singularity University and of OpenExo. In relation to the organizations that Mr. De la Parra has collaborated with for social impact and empowerment, he is a member of the Laurentia Project and of Cerebro Mexico, he serves as an Advisory Board member of the Lifeboat Foundation, as an Advisory Board member of the Future Worlds Center – Cyprus Neuroscience & Technology Institute (Senior TV Program), while also being a Federated Member of the International Longevity Alliance and a member of the Transhumanist Party. He is a voting citizen and is running for Mayor & future Parliamentary Candidate at Asgardia. He served as the Chief Digital Strategy Officer and is Member of the Board of Advisors and an Honorary Member at the Transdisciplinary Agora for Future Discussions, a member of the Web Committee at the Life Extension Advocacy Foundation/Lifespan.io, volunteered with SENS Research Foundation for the OncoSENS Program in Digital Strategy, and acted as Digital Strategy adviser at the Major Mouse Testing Program. He also functioned as the founder and former Board of Directors member of Astrum Fundación and was Digital Strategy Advisor for POKI Ciudad Orgánica. He is also a part of the General Member Board at the National Autism Association, the National Fibromyalgia Association, the International Literacy Association, and the United Spinal Association. De la Parra-Solomon is also a member of several associations for technology including the World Blockchain Association, the EU Blockchain Observatory & Forum, the Blockchain Industry Group, the Computing Technology Industry Association, the Internet Marketing Association, the Application Developers Alliance, and the Association of Strategic Marketing. For the energy sector, he worked as the Vice President of Strategy & Operations of PetroM Energy and is a member of the National Introducing Brokers Association and a part of the National Biodiesel Board (Alliance Program). De la Parra-Solomon’s activities in arts & culture involve being a member of Sociedad de Autores y Compositores de México, while also being a member of the Executive Board at Sociedad Latinoamericana de Ópera. He also served as Digital Strategy Advisor at Xicome Festival. He is a media professional at IMDB, SoundCloud, and ReverbNation and has had activities in the entertainment industry as a music producer, composer & arranger for Televisa with broadcast television, film, radio, and web, receiving international awards with aired content in more than 185 countries.

Susanna Uusmaa is a biomedical scientist with broad expertise in Medical Sciences and in International Business. Holding an MSBS degree, she is result-driven to integrate modern smart technologies into making substantive contributions to the biomedical sector. Having conducted research in neuroscience and oncology and having proudly graduated from Tallinn University of Technology (TALTECH) and Tallinn University School of Natural Sciences and Health, Uusmaa takes an evidence-based approach to her professional objectives and also to her endeavors as a passionate healthy lifestyle entrepreneur. With a background in biomolecular and medical sciences, she has recently co-founded Quantum Brain Research Institute with the aim of supporting the development of neuroscientific research for neurocritical treatment applications through instructive programs in mental health assessment and management. In collaboration with the Luxembourg Institute of Health and Luxembourg Centre for Systems Biomedicine, she developed a complete standard operating procedure for differentiating and generating fully functional glial cells from induced pluripotent stem cells (iPSCs) in only 30 days. Moreover, she holds over 6 years of hard-working experience in business operations and relationship building in more than 5 countries around the globe, having created and nurtured mutually beneficial partnerships, enhanced workflow efficiency, and contributed to the growth of several initiatives with substantial savings. Ms. Uusmaa’s biomedical undertakings have positioned her as an MSBS to be able to become an active contributor also to the longevity sector and put her expertise into helping people become their best version of themselves with properly validated and ethical practices. She considers herself lucky to be born in the beautiful Northern European city of Tallinn in Estonia, a UNESCO World Heritage treasure of the Baltic Sea, where women’s rights are valued and where cutting-edge technologies are implemented in e-governance and healthcare. Uusmaa brings strong organizational and unique interpersonal abilities to her scope of action with the ultimate goal of integrating smart and efficient solutions to the biomedical sector and creating awareness of healthy living & healthy aging.

Hemant Dhamne is an expert in the field of cell and gene therapy with specific experience in building and operating Products, Processes, Analytical Development, and Manufacturing functions. He has done a Ph.D. in Viral Vectors/Gene Therapy followed by a Postdoc in Functional Genomics. Later he worked with Intas Pharmaceuticals for AAV Gene Therapy and most recently with Immuneel Therapeutics for CAR-T cell therapy. He also holds a diploma in International Business and Medical Diagnostics. At present, he is heading the Process Development function at Gene Therapy Vector Facility, King's College London. He has previously led the team delivering pre-IND & IND applications for AAV-8 FIX, AAV8-FVIII, and CD19-CAR T products. He built the capability and infrastructure for cell and gene therapy in India and was the key person to bringing the CGT wave to his country. Besides this, Hemant also indulges in Indian classical music, learning vocals and bamboo flutes.

Lakshimipriya Sethuram is a Senior research fellow at the Vellore Institute of Technology, India. She received her Senior research fellowship (SRF) from the Council of Scientific and Industrial Research (CSIR), India in 2020. Her research mainly focuses on the design and fabrication of nanomaterials for the treatment of acute and chronic wound healing applications. She is enthusiastic and passionate about exploring new innovations in skin regeneration and tissue engineering approaches (especially in chronic wounds) in order to deal with today's challenges in chronic wound care. She has published her research outcomes in peer-reviewed international scientific journals. Her recent work has been published as a front cover page entitled "A review on contemporary nanomaterial-based therapeutics for the treatment of diabetic foot ulcers (DFUs) with special reference to Indian Scenario" in Nanoscale Advances (Royal Society of Chemistry). She was awarded Research Excellence Award in 2020 from InSC Scholars (International Accurate Certification).